News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Medivir AB (MVIRb.F) Announces That Simeprevir (TMC435) Data Will be Presented at the Upcoming American Association for Study of Liver Diseases Meeting


10/1/2012 10:39:08 AM

STOCKHOLM--(BUSINESS WIRE)--Regulatory News: Medivir AB (STO:MVIRB), announced today that four abstracts related to simeprevir (TMC435), have been accepted for presentation at the 63nd Annual Meeting of the American Association for the Study of Liver Diseases (AASLD), taking place from November 9-13 in Boston, USA.

Read at BioSpace.com

Related News

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES